Bystolic - 2007 FDA approvals

Drug: Bystolic (nebivolol)
Indication: Hypertension
Company: Forest Laboratories and Mylan
Approval Date: Decembe 18, 2007

Scoop: Bystolic is the 19th approved beta blocker available in the U.S. The drug's developers say it has "placebo-like" side effects, making compliance easier for patients with high blood pressure.

More News:
New "me-too" beta blocker dissed by experts. Report

Bystolic - 2007 FDA approvals
Read more on

Suggested Articles

Horizon Therapeutics is expanding its U.S. footprint to the Bay Area—the company unveiled a new R&D and manufacturing site in South San Francisco.

Azeria Therapeutics has raised £32 million ($41 million) to take its estrogen receptor positive breast cancer program into the clinic.

Biogen’s Al Sandrock has given a bullish assessment of Alzheimer’s disease drug aducanumab. The head of R&D at Biogen thinks the drug works, despite i